BDBM28292 1,3,4-oxadiazole substituted naphthyridine, 60::7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-5-(1H-pyrazol-1-yl)-1,6-naphthyridin-8-ol
SMILES: Oc1c(nc(-n2cccn2)c2cccnc12)-c1nnc(Cc2ccc(F)cc2)o1
InChI Key: InChIKey=UJVASEBGZBXOTD-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HIV-1 Integrase (Human immunodeficiency virus type 1) | BDBM28292![]() (1,3,4-oxadiazole substituted naphthyridine, 60 | 7...) | PDB MMDB UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
GSK | Assay Description Purified recombinant integrase was first combined in a complex with biotinylated donor DNA- streptavidin-coated SPA beads. The complex was preincubat... | Bioorg Med Chem Lett 19: 1807-10 (2009) Article DOI: 10.1016/j.bmcl.2009.01.089 BindingDB Entry DOI: 10.7270/Q2TH8K1R | |||||||||||
More data for this Ligand-Target Pair |